Published in Br J Cancer on July 01, 1991
Ifosfamide--pharmacology, safety and therapeutic potential. Cancer Treat Rev (1985) 2.20
Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol (1990) 2.20
Chemotherapy of sarcoma. A comparison of three regimens. Lancet (1978) 1.75
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol (1989) 1.69
P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol (1987) 1.64
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol (1989) 1.55
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol (1987) 1.53
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Phase II evaluation of adriamycin in human neoplasia. Cancer (1973) 1.40
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer Clin Oncol (1987) 1.01
Ifosfamide--current aspects and perspectives. Cancer Treat Rev (1983) 1.01
A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma. Cancer (1982) 1.00
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer (1984) 0.96
Chromosomal changes in soft-tissue sarcomas. A new diagnostic parameter. Arch Surg (1987) 0.92
Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study. Eur J Cancer Clin Oncol (1983) 0.91
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1990) 0.89
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613). J Clin Oncol (1987) 0.86
Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma? J Clin Oncol (1987) 0.86
Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy. Cancer (1981) 0.83
A phase I-II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma. Eur J Cancer Clin Oncol (1988) 0.81
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas. Cancer Chemother Pharmacol (1985) 0.81
Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies. Int J Cancer (1989) 0.81
Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP). Cancer Treat Rep (1981) 0.79
A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma. Cancer Chemother Pharmacol (1988) 0.79
Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy. Can J Surg (1988) 0.79
Cyclophosphamide, doxorubicin, and cisplatin combined in the treatment of advanced sarcomas. Med Pediatr Oncol (1983) 0.78
Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas. Isr J Med Sci (1989) 0.78
Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination. Cancer Chemother Pharmacol (1985) 0.78
Results of the Royal Marsden Hospital second soft tissue sarcoma schedule (STS II) chemotherapy regimen in the management of advanced sarcoma. Cancer Treat Rep (1981) 0.77
Chemotherapy of adult soft tissue sarcoma with combination of doxorubicin and methotrexate. Cancer Treat Rep (1987) 0.77
Combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomas. Eur J Cancer Clin Oncol (1982) 0.77
Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7). Cancer (1982) 0.77
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. J Natl Cancer Inst (2009) 4.24
Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases. Lancet (1998) 2.75
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33
Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol (1988) 1.93
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer (2001) 1.91
Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet (1984) 1.56
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol (1987) 1.53
The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med (2001) 1.45
Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2. Lancet (1992) 1.40
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer (1984) 0.96
Cyclophosphamide versus ifosfamide: preliminary report of a randomized phase II trial in adult soft tissue sarcomas. Cancer Chemother Pharmacol (1986) 0.96
Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study. Invest New Drugs (1988) 0.95
Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care? J Clin Oncol (2001) 0.93
Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study. Eur J Cancer Clin Oncol (1983) 0.91
Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester. Br J Cancer (1985) 0.91
Activity of JM9 in advanced ovarian cancer: a phase I-II trial. Cancer Treat Rep (1985) 0.90
Pyomyositis after chemotherapy for breast cancer. Am J Clin Oncol (2000) 0.89
Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study? Eur J Cancer (1999) 0.84
Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial. Breast Cancer Res Treat (2011) 0.83
Adjuvant chemotherapy in the treatment of soft-tissue sarcoma. Clin Orthop Relat Res (1993) 0.82
Studies of lectin binding to normal and neoplastic lymphoid tissues. I. Normal nodes and Hodgkin's disease. Br J Cancer (1982) 0.81
Studies of lectin binding to normal and neoplastic lymph nodes. II. Non-Hodgkin's lymphoma. Br J Cancer (1982) 0.79
Carcinomatous meningitis associated with infiltrating lobular carcinoma of the breast. Eur J Surg Oncol (1985) 0.79
Dibromodulcitol, mitomycin C and vinblastine (DMV) chemotherapy in advanced breast cancer. Eur J Cancer Clin Oncol (1984) 0.78
Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol (1991) 0.78
E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma. Eur J Cancer (1979) 0.78
Intermediate dose single agent cyclophosphamide chemotherapy of advanced breast cancer. Clin Oncol (1983) 0.78
Evaluation of adjuvant therapy in soft tissue sarcoma. A collaborative multidisciplinary approach. E.O.R.T.C. protocol 62771. Eur J Cancer (1979) 0.77
Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma. N Engl J Med (1993) 0.77
Sustained oral indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced renal cell carcinoma. Cancer Biother (1993) 0.77
Adjuvant chemotherapy for soft tissue sarcomas. Hematol Oncol Clin North Am (1995) 0.77
Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials Group. Eur J Cancer Clin Oncol (1984) 0.76
Osteosarcoma and other tumors of bone. Curr Opin Oncol (1996) 0.75
VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer. Cancer Treat Rep (1982) 0.75
Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced malignant melanoma: a phase II study. Clin Oncol (R Coll Radiol) (1993) 0.75
Soft tissue sarcoma in adults. Curr Opin Oncol (1993) 0.75
Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group. Cancer Treat Rep (1981) 0.75
Adjuvant chemotherapy for soft tissue sarcomas. Cancer Treat Res (1989) 0.75
Adjuvant chemotherapy for soft tissue sarcomas. Cancer Treat Res (1991) 0.75
Adjuvant treatment of soft tissue sarcoma in children and adults. Recent Results Cancer Res (1978) 0.75
Bone marrow involvement in adult soft tissue sarcomas. Eur J Cancer Clin Oncol (1982) 0.75
Adjuvant chemotherapy of soft tissue sarcomas. Cancer Treat Res (1993) 0.75
High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets. Cancer Immunol Immunother (1995) 0.75